Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. 11:02:22 14/08/2026 BST			5-day change	1st Jan Change
2,480.60 ^INR	-0.71%		-3.67%	+34.73%

08-12	Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-12	Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year ended March 31, 2026, Payable on October 24, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	189,896	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	24.75%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	189,896	189,896	189,896
Change	-	68.55%	-12.11%	120.88%	52.16%	24.75%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	25.8x	23.4x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.17x	3.92x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.3x	2.3x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.59x	6.77x
EV / Revenue	0x	0x	0x	0x	0x	8.92x	7.59x	6.77x
EV / EBITDA	0x	0x	0x	0x	0x	25.6x	21.6x	19.4x
EV / EBIT	0x	0x	0x	-	0x	24.4x	20.4x	17.7x
EV / FCF	0x	0x	0x	0x	0x	50x	31.8x	35.1x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	3.15%	2.85%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	97	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.12%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	25,008	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,792	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,369	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,498.25	2,498.25	2,498.25
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	06/05/21	12/05/22	27/05/23	16/05/24	15/05/25	14/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	30.8x	-	-	-	1.99B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.65x	6.69x	23.19x	0.88%	48.57B
OTSUKA HOLDINGS CO., LTD.	19.4x	2.3x	10.51x	1.32%	40.99B
CIPLA LIMITED	28.4x	3.46x	17.93x	0.89%	12.35B
ZYDUS LIFESCIENCES LIMITED	27.99x	3.98x	16.37x	0.6%	12.2B
KRKA, D. D.	18.73x	3.33x	11.58x	3.85%	9.08B
GEDEON RICHTER	8.97x	2.07x	5.38x	4.48%	7.41B
ONO PHARMACEUTICAL CO., LTD.	15.91x	2.06x	6.44x	3.24%	7.13B
GLENMARK PHARMACEUTICALS LIMITED	35.22x	4.02x	17.1x	0.23%	6.86B
Average	24.56x	3.49x	13.56x	1.94%	16.29B
Weighted average by Cap.	26.41x	4.14x	15.81x	1.44%